A model for the number of cores per prostate biopsy based on patient age and prostate gland volume

Journal of Urology

Volumn 159, Issue 3, 1998, Pages 920-924

  Vashi, Apoorva R ^a   Wojno, Kirk J ^a   Gillespie, Brenda ^a   Oesterling, Joseph E ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Biopsy; Cancer; Diagnosis; Prostate

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER DIAGNOSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; TUMOR BIOPSY; TUMOR VOLUME;

EID: 0031905976     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)63771-6     Document Type: Article

References (26)

1. Brawer, M. K., Chetner, M. P., Beatie, J., Buchner, D. M., Vessela, R. L. and Lange, P. H.: Screening for prostatic carcinoma with prostate specific antigen. J. Urol., 147: 841, 1992.
2. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T. and Flanigan, R. C.: Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men. J. Urol., 151: 1283, 1994.
3. Catalona, W. J., Smith, D. S., Ratliff, T. L. and Basler, J. W.: Detection of organ confined cancer is increased through prostate specific antigen based screening. J.A.M.A., 270: 948, 1993.
4. Hodge, K. K., McNeal, J. E. and Stamey, T. A.: Ultrasound guided transrectal core biopsies of the palpably abnormal prostate. J. Urol., 142: 66, 1989.
5. Hodge, K. K., McNeal, J. E., Terris, M. K. and Stamey, T. A.: Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J. Urol., 142: 71, 1989.
6. Uzzo, R. G., Wei, J. T., Waldbaum, R. S., Perlmutter, A. P., Byrne, J. C. and Vaughan, E. D., Jr.: The influence of prostate size on cancer detection. Urology, 46: 831, 1995.
7. Karakiewicz, P. I., Bazinet, M., Aprikian, A. G., Trudel, C., Aronson, S., Nachabe, M., Peloquint, F., Dessureault, J., Goyal, M. S., Begin, L. R. and Elhilali, M. M.: Outcome of sextant biopsy according to gland volume. Urology, 49: 55, 1997.
8. Stricker, H. J., Ruddock, L. J., Wan, J. and Beleville, W. D.: Detection of non-palpable cancer: a mathematical and laboratory model. Brit. J. Urol., 71: 43, 1993.
9. Eskew, L. A., Bare, R. L. and McCullough, D. L.: Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J. Urol., 157: 199, 1997.
10. Life tables. In: Vital Statistics of the United States. Washington, D. C.: United States Bureau of the Census, section 6, pp. 1-19, 1990.
11. Life tables. In: Vital Statistics of the United States. Washington, D. C.: United States Bureau of the Census, section 7, pp. 22-23, 1990.
12. Czapo, Z., Brand, K., Walther, R. and Konstantinos, F.: Comparitive experimental study of the serum prostate specific antigen and prostatic acid phosphatase in serially transplantable human prostatic carcinoma cell lines in nude mice. J. Urol., 140: 1032, 1988.
13. Schmid, H., McNeal, J. E. and Stamey, T. A.: Observations on the doubling time of prostate cancer: the use of serial prostate-specific antigen in patients with untreated disease as a measure of increasing cancer volume. Cancer, 71: 2031, 1993.
14. Stamey, T. A.: Making the most out of six systematic biopsies. Urology, 45: 2, 1995.
15. Dugan, J. A., Bostwick, D. G., Myers, R. P., Qian, J., Bergstralh, E. J. and Oesterling, J. E.: The definition and preoperative prediction of clinically insignificant prostate cancer. J.A.M.A., 275: 288, 1996.
16. Bostwick, D. G., Graham, S. D. and Napalkov, P.: Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology, 41: 403, 1993.
17. Bastacky, S. I., Wojno, K. J., Walsh, P. C., CarMichael, M. J. and Epstein, J. I.: Pathological features of hereditary prostate cancer. J. Urol. 153: 987, 1995.
18. Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S. and Schmid, H. P.: Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer, 71: 933, 1993.
19. Epstein, J. I., Walsh, P. C., CarMichael, M. and Brendler, C. B.: Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. J.A.M.A., 271: 368, 1994.
20. Berges, R. R., Vukanovic, J., Epstein, J. I., CarMichael, M., Cisek, L., Johnson, D. E., Veltri, R. W., Walsh, P. C. and Isaacs, J. T.: Implication of cell kinetic changes during the progression of human prostate cancer. Clin. Cancer Res., 1: 473, 1995.
21. McNeal, J. E., Villers, A. A., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Histologic differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer, 66: 1225, 1990.
22. Stamey, T. A., McNeal, J. E., Freiha, F. S. and Redwine, E. A.: Morphometric and clinical studies on 68 consecutive radical prostatectomies. J. Urol., 139: 1235, 1988.
23. McNeal, J. E., Redwine, E. A., Freiha, F. S. and Stamey, T. A.: Zonal distribution of prostatic adenocarcinoma: correlation with histologic patterns and direction of spread. Amer. J. Surg. Path., 12: 897, 1988.
24. Wojno, K. J.: Personal communication.
25. McNeal, J. E. and Haillot, O.: The anatomy of a cancer: prostatic adenocarcinoma. Amer. J. Surg. Path., in press.
26. Chen, M. E., Troncoso, P., Johnston, D., Tang, K. and Babaian, R. J.: Optimization of prostate biopsies using computer based analysis. J. Urol., part 2, 157: 64, abstract 246, 1997.